LEVIN ILAN enters SILEXION THERAPEUTICS CORP with 1.89M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 8/15/2024ACC: 0001213900-24-069884
Director10% Owner
Since Aug 2025
1.89M
Baseline shares
0.00
Direct ownership
0 positions
176.43K
Derivative underlying
1 instrument
2
Security positions
1.89M indirect
Non-Derivative Holdings2
Ordinary Shares
IndirectShares owned1.69M
Ordinary Shares
IndirectShares owned200K
Total
1.89M indirect1.89M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 1.69M | Indirect |
| Ordinary Shares | 200K | Indirect |
| Total | 1.89M | 1.89M indirect |
Derivative Holdings1
Warrant to purchase ordinary shares
IndirectUnderlying security
Ordinary Shares
Underlying shares
176.43K
Shares owned
N/A
Exercise price
11.50
Expiration
—
Exercise window
—
Total
Underlying
176.43K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrant to purchase ordinary shares Indirect | Ordinary Shares | 11.50 | — | — | 176.43K | N/A |
| Total | 176.43K | 0.00 | ||||